glp-1 cancer risk Dr New study examines GLP-1 drugs
Description
Once-Weekly Semaglutide Induces an Early Improvement in Body Composition in Patients with Type 2 Diabetes: A 26-Week Prospective Real-Life Study
Gastroenterology 163 , 386402
Subject to current FDA 503A regulatory posture Compounded tirzepatide from 2.5mg/wk to 15mg/wk
J., Bravo, D
High post-meal glucose spikes despite adequate fasting glucose control
These are pharmaceutical-grade products manufactured by Eli Lilly
